Short stature with normal growth hormone stimulation testing: lack of evidence for partial growth hormone deficiency or insensitivity
Department of Pediatrics, Division of Endocrinology
Medical Subject Headings
Adolescent; Adrenergic alpha-Agonists; Arginine; Body Weight; Child; Clonidine; Dwarfism, Pituitary; Female; Humans; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Retrospective Studies
Endocrinology, Diabetes, and Metabolism | Pediatrics
OBJECTIVES: To test the hypothesis that children with short stature and peak stimulated GH (pGH) of 7-10 microg/l have partial GH deficiency and to test the hypothesis that short children with normal pGH but low IGF-I levels have partial GH deficiency or partial GH insensitivity.
DESIGN AND PATIENTS: Retrospective analysis of the clinical and biochemical profiles of 76 children who underwent an evaluation for short stature (height < 5th percentile) that included two, sex steroid-primed GH stimulation tests.
RESULTS: Patients with pGH < 7 microg/l (n = 14) differed significantly from those with pGH > 7 microg/l (n = 62), having greater midparental height (MPH) SDS, a greater disparity between height SDS and MPH SDS, and lower IGF-I SDS. Patients with pGH of 7-10 microg/l (n = 12) did not have characteristics intermediate between those with pGH < 7 microg/l and those with pGH > or = 10 microg/l, but instead resembled those with pGH > or = 10 microg/l. Patients with pGH > or = 7 microg/l, but low IGF-I (< -2 SDS) (n = 5), did not show characteristics intermediate between those with pGH < 7 microg/l and those with pGH > or = 7 microg/l and normal IGF-I.
CONCLUSIONS: These data do not support either the hypothesis that children with pGH of 7-10 microg/l have partial GH deficiency or the hypothesis that children with normal pGH but subnormal IGF-I levels have partial GH deficiency or insensitivity.
Rights and Permissions
Citation: Horm Res. 2004;62(2):97-102. Epub 2004 Jul 13. Link to article on publisher's site